Circulating microparticle levels in patients with coronary artery disease: A new indicator of vulnerability?

European Heart Journal

Volumn 32, Issue 16, 2011, Pages 1958-1960

  Amabile, Nicolas ^a,b   Boulanger, Chantal M ^a,c  

^a PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^b CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CD31 ANTIGEN; LIPOCORTIN 5; PHOSPHOLIPASE A2;

APOPTOSIS; ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; CELL PROLIFERATION; CHRONIC KIDNEY FAILURE; CORONARY ARTERY DISEASE; ENDOTHELIAL MICROPARTICLE; FLOW CYTOMETRY; FRAMINGHAM RISK SCORE; HUMAN; IN VIVO STUDY; LEUKOCYTE MICROPARTICLE; MEMBRANE MICROPARTICLE; PARTICLE SIZE; PLATELET MICROPARTICLE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; REVIEW; THROMBOCYTE AGGREGATION;

ANNEXIN A5; ANTIGENS, CD31; CELL-DERIVED MICROPARTICLES; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE;

EID: 80051970227     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehr055     Document Type: Review

References (12)

1. Ambrose JA, Srikanth S. Vulnerable plaques and patients: improving prediction of future coronary events. Am J Med 2010;123:10-16.
2. Weintraub HS. Identifying the vulnerable patient with rupture-prone plaque. Am J Cardiol 2008;101(12 Suppl 1):S3-S10.
3. Hlatky MA, Greenland P, Arnett DK, Ballantyne CM, Criqui MH, Elkind MSV, Go AS, Harrell FE Jr, Hong Y, Howard BV, Howard VJ, Hsue PY, Kramer CM, McConnell JP, Normand S-LT, O'Donnell CJ, Smith SC Jr, Wilson PW; American Heart Association Expert Panel on Subclinical Atherosclerotic Diseases and Emerging Risk Factors and the Stroke Council. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation 2009;119:2408-2416.
4. Sinning JM, Losch J,Walenta K, Bohm M, Nickenig G,Werner N. Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes. Eur Heart J 2011; 32:2034-2041. First published on 24 December 2010. doi: 10.1093/eurheartj/ehq478.
5. Amabile N, Rautou PE, Tedgui A, Boulanger CM. Microparticles: key protagonists in cardiovascular disorders. Semin Thromb Hemost 2010;36:907-916.
6. Nozaki T, Sugiyama S, Koga H, Sugamura K, Ohba K, Matsuzawa Y, Sumida H, Matsui K, Jinnouchi H, Ogawa H. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease. J Am Coll Cardiol 2009;54: 601-608.
7. Amabile N, Heiss C, Chang V, Angeli FS, Damon L, Rame EJ, McGlothlin D, Grossman W, De Marco T, Yeghiazarians Y. Increased CD62e(+) endothelial microparticle levels predict poor outcome in pulmonary hypertension patients. J Heart Lung Transplant 2009;28:1081-1086.
8. Amabile N, Boulanger CM, Guerin AP, Tedgui A, London GM. Circulating endothelial microparticles: a novel biomarker for prediction of subsequent death and cardiovascular events in end-stage renal disease. Circulation 2009; 120:S1010.
9. Werner N, Wassmann S, Ahlers P, Kosiol S, Nickenig G. Circulating CD31+/annexin V+ apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2006; 26:112-116. (Pubitemid 43732236)
10. Fichtlscherer S, Breuer S, Zeiher AM. Prognostic value of systemic endothelial dysfunction in patients with acute coronary syndromes: further evidence for the existence of the 'vulnerable' patient. Circulation 2004;110:1926-1932. (Pubitemid 39331903)
11. Angiolillo DJ, Bernardo E, Sabate M, Jimenez-Quevedo P, Costa MA, Palazuelos J, Hernandez-Antolin R, Moreno R, Escaned J, Alfonso F, Banuelos C, Guzman LA, Bass TA, Macaya C, Fernandez-Ortiz A. Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol 2007;50:1541-1547. (Pubitemid 47532327)
12. Boulanger CM, Scoazec A, Ebrahimian T, Henry P, Mathieu E, Tedgui A, Mallat Z. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 2001;104:2649-2652. (Pubitemid 33108128)